From Booth to Bavaria: A Recap of Impact at ESC 2026
September 7, 2026 | CME, Cardiology Education, IME, Patient Impact, cardiology
We have officially wrapped up another year at ESC. For Medscape Education, 4 days on the ground confirmed what 3 decades of cardiovascular education have already shown: when independent, evidence-based education meets clinicians where they are, we are able to change clinical behavior and practice.
Across the 4 independently developed symposia, we welcomed 1,300+ cardiologists and cardiovascular specialists.
Add to that a steady stream of visitors to the booth, some who were experiencing Medscape AI for the first time, including one of our members from Sri Lanka who noted, “The new AI tool looks great. It gives a lot of versatility to users so they can work through their clinical problems on Medscape and get a better, wider opinion. I think this new AI tool might be a game-changer.”
Beyond the booth, we hosted an invite-only evening at the Hofbräuhaus where Carolyn Lam, MBBS, PhD and Manesh Patel, MD led a fireside chat on AI’s role in cardiovascular care, ESC 2026 becomes another key event and part of a much longer story about closing gaps in cardiology education.
Why does it matter?
This congress didn’t happen in isolation. It builds on a foundation of 695,882 cardiology HCPs reached globally and 387,772 cardiologist learners engaged year-round, work that translates into measurable outcomes: 93% of learners report our activities improve patient care, and advanced-outcomes programming shows a 46% improvement in knowledge and competence.
ESC 2026 was a chance to put that evidence into practice, in person, with the clinicians shaping the future of cardiovascular care.
Source: Medscape Internal Data 2026
For more information on Medscape’s cardiology education, please reach out to your Medscape Education representative.
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
Hear From Her: Announcing The Women in Healthcare Leadership Series Podcast
On the 8th November 2023, Medscape will launch the first episode of their new podcast: the Women in Healthcare Leadership Podcast Series.This insightful series was designed to elevate and empower…
Medscape Education Invites Listeners to ‘Hear From Her’ With New Women in Healthcare Leadership Podcast Series
Medscape Education has launched their new podcast: the Women in Healthcare Leadership Podcast Series. The series, hosted by Medscape Education employees, features women in leadership roles across industry as well…
Sharing Outcomes in MS at ECTRIMS 2023
During ECTRIMS 2023 congress, the Medscape Education Global team will be on site to present a poster of their educational outcomes.The poster, Virtual Patient Simulation Improves Neurologists’ Performance in Making…
Shining a Light on Current Topics in Oncology
The Medscape Oncology team will be on the road again, this time in Madrid, Spain for ESMO 2023. This year, the team will be sharing education with a deep impact…
Disseminating Outcomes and Impact in Berlin
The Medscape Education Global team is looking forward to a busy time in Berlin at the EADV Congress 2023. During the congress, Medscape will be presenting five posters examining the…
Medscape Education’s Large Presence at IDWeek 2023
Medscape are powering education and disease state awareness in infectious diseases at #IDWeek 2023
Contagious Conversations: Exploring Infectious Disease in the Digital Age
As the world of medicine continues to evolve, it’s crucial to stay ahead of the curve. In this dynamic era, digital communications have emerged as a driving force in discussions…
Presenting Outstanding Outcomes from HCP Education in Multiple Myeloma at IMS in Athens
From September 27-30, members of the Medscape Education Global team were in Athens, Greece sharing 5 posters at the International Myeloma Society Annual Meeting, 2023.The posters presented the outcomes and…
Impacting Lives with Rare Disease Education
Education on rare diseases is crucial. Estimates suggest there are approximately 10,000 rare diseases, with 263–446 million people affected worldwide.Since its launch in September 2022, the Medscape Pathways in Rare…
Medscape’s Virtual Patient Simulation Makes a Significant Impact on Real-World Treatment Selection for T2D
An analysis of data using Real-World Outcomes showed that a virtual patient simulation had a significant effect on real-world treatment selection for T2D. The paper, published in JMIR Medical Education,…